Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: Data concerning appropriate treatment in panic disorder following an initial response to acute therapy are limited. Aims: To assess the safety and efficacy of continued fluoxetine treatment following successful acute therapy of panic disorder. Method: Patients who responded to acute fluoxetine treatment were randomised to 24 weeks of continued fluoxetine or placebo. Results: Fluoxetine responders randomised to continue on their acute-phase fluoxetine dose experienced statistically significant improvement in panic attack frequency and phobia rating scale score over 24 weeks of therapy, while those switched to placebo experienced statistically significant worsening in Hamilton Anxiety (HAM–A), Hamilton Depression (HAM–D) and SCL–90–R rating scores. Conclusions: Fluoxetine was associated with improved clinical outcomes compared with placebo during continuation therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
PRICE, J. S., WALLER, P. C., WOOD, S. M., & MACKAY, A. V. P. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00498.x · Cited by 171
Long‐term evaluation of paroxetine, clomipramine and placebo in panic disorder
Lecrubier, Y., Judge, R., & The Collaborative Paroxetine Panic Study Investigators (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00389.x · Cited by 139
Long-term drug treatment of panic disorder
Burrows, G. D., Judd, F. K., & Norman, T. R. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90022-t · Cited by 19
Research works printed but not linked: 18
- Pyloe, 1995, Paroxetine withdrawal syndrome [Letter], American Journal of Psychiatry, 152, 149, 10.1176/ajp.152.1.149b · DOI
- Noyes, 1989, Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study, Journal of Clinical Psychiatry, 50, 163
- 10.1001/archpsyc.1989.01810110035005 · DOI · Paper page
- 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
- 10.1176/ajp.155.11.1570 · DOI · Paper page
- Derogatis, 1974, Psychological Measurements in Psychopharmacology: Problems in Psychopharmacology., 79
- Aronson, 1987, A naturalistic study of imipramine in panic disorder and agoraphobia, American Journal of Psychiatry, 144, 1014, 10.1176/ajp.144.8.1014 · DOI
- 10.1001/archpsyc.1994.03950050006001 · DOI · Paper page
- 1987, Diagnostic and Statistical Manual of Mental Disorders
- Pollack, 1995, The longitudinal course and outcome of panic disorder [Review], Psychiatric Clinics of North America, 18, 785, 10.1016/S0193-953X(18)30023-6 · DOI
- Judge, 1996, Xth World Congress of Psychiatry, Madrid, Vol. 2
- Spitzer, 1986, The Structured Clinical Interview for DSM–III–R (SOD).
- 10.1016/0022-3956(93)90023-U · DOI
- Pollack, 1988, Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up, Journal of Clinical Psychopharmacology, 6, 302
- Guy, 1974, ECDEU Assessment Manual for Psychopharmacology, 218
- 10.1097/00004714-199302000-00003 · DOI
- Hamilton, 1969, Diagnosis and rating of anxiety, British Journal of Psychiatry, 113, 76
- Sneehan, 1983, The Anxiety Disease.
Cited by
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Batelaan, N. M., Bosman, R. C., Muntingh, A., Scholten, W. D., Huijbregts, K. M., & van Balkom, A. J. L. M. (2017) · BMJ · doi:10.1136/bmj.j3927 · Cited by 153
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Sertraline treatment of panic disorder: results of a long-term study
Rapaport, M. H., Wolkow, R., Rubin, A., Hackett, E., Pollack, M., & Ota, K. Y. (2001) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2001.00263.x · Cited by 79
Self-citationRisks and benefits of medications for panic disorder: A comparison of SSRIs and benzodiazepines
Quagliato, L. A., Freire, R. C., & Nardi, A. E. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1429403 · Cited by 62
“to placebo with no tapering period [13].”
Background
Metadata
- Authors
- Michelson, D., Pollack, M., Lydiard, R. B., Tamura, R., Tepner, R., Tollefson, G., & The Fluoxetine Panic Disorder Study Group
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1999-03
- Volume
- 174
- Issue
- 3
- Pages
- 213-218
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2126900598
- Cited by
- 54
- References
- 4
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.